5:48 PM
 | 
Oct 22, 2013
 |  BC Extra  |  Company News

FDA panel to discuss pediatric cancer products

FDA's pediatric oncology subcommittee will meet on Nov. 5 to discuss pediatric development plans for three cancer compounds. The products to be discussed are nivolumab ( BMS-936558) from Bristol-Myers Squibb Co. (NYSE:BMY);...

Read the full 153 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >